Antifungal Foot Care
NDC Package 69276-166-18

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Antifungal Foot Care is a . Marketed by Neobourne Pharma Lp, this product is identified by NDC 69276-166 and is authorized under FDA application part333C.

Identification & Billing

NDC Package Code
69276-166-18
Package Description
180 g in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
69276016618

Clinical Specifications

Proprietary Name
Antifungal Foot Care
Dosage Form
-

Regulatory & Marketing

Labeler Name
Neobourne Pharma Lp
FDA Application #
part333C
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-16-2015
End Marketing Date
11-29-2017
Listing Expiration
11-29-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69276-166). Click a package code to view its specific billing and regulatory data.

60 g in 1 BOTTLE, SPRAY

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69276-166-18 identifies a specific commercial package of 180 g in 1 bottle, spray of Antifungal Foot Care, labeled by Neobourne Pharma Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neobourne Pharma Lp on March 16, 2015. The current certification is valid through November 29, 2017.

How is this Neobourne Pharma Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69276016618. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69276-166-18
11-Digit CMS (5-4-2)
69276-0166-18

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.